KromaTiD

Longmont, CO · Founded 2007 · Privately Held (backing)

Developer of next-gen cytogenetic products focused on discovering, detecting, and diagnosing genomic rearrangements in the areas of oncology and rare diseases. KromaTiD is based in Longmont, CO and was founded in 2007. It was valued at $39 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $23.6 million across 5 recorded rounds; the latest was a $3.6 million seed round in Jul 2025.

PMV mark · valuation
$39.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$23.6M
Last round
Seed Round
Jul 2025

Who backs KromaTiD?

11 investors
InvestorType
National Institutes of HealthOther
Innosphere VenturesOther
Colorado Office of Economic Development & International TradeOther
BroadOak Capital Partners—
CSU Starta—
Colorado Institute for Drug—
Colorado State University—
Colorado Venture Capital Authority—
Device and Diagnostic Development—
First Capital Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

KromaTiD investors

11 investors are on record for KromaTiD, including National Institutes of Health, Innosphere Ventures, Colorado Office of Economic Development & International Trade and BroadOak Capital Partners. The seed round in Jul 2025 drew 57 investors.

Free account
More of KromaTiD with a free account
  • ·The complete investor list: 11 names
  • ·Watch KromaTiD: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like KromaTiD. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View